Company / Cost of Revenue
Teladoc Health, Inc. Cost of Revenue History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$744.0M
FY2022
5-year range
$650.3M / $744.0M
FY2018-FY2022
Trend
+14.4%
vs FY2021
Sector context
#54 of 107
Health Care
What the data says
At $744M, Teladoc Health, Inc.'s cost of revenue ranks #54 of 107 in the Health Care sector. Cost of Revenue has increased for 6 consecutive years, from $32M in FY2016 to $744M in FY2022.
Based on SEC 10-K filings.
$744M in FY2022 with a 5-year CAGR of +64.6%.
Increased from $391M to $744M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +59.2%
- 5-Year CAGR
- +64.6%
- 10-Year CAGR
- -
Sector benchmark
#54 of 107 in Health CareTop 50% of 107This company $744.0M Sector average $11.8B
▼
-93.7% below sector average
Key checks
Key Insights
- Teladoc Health, Inc.'s cost of revenue has grown for 6 consecutive years.
- 5-year CAGR of +64.6%, indicating consistent growth.
- In FY2022, cost of revenue increased 14.4% year-over-year.
- Ranks #54 out of 107 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $744.0M | +14.4% |
| FY2021 | $650.3M | +66.4% |
| FY2020 | $390.8M | +111.9% |
| FY2019 | $184.5M | +43.3% |
| FY2018 | $128.7M | +108.9% |
| FY2017 | $61.6M | +92.7% |
| FY2016 | $32.0M | +51.9% |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026